Modulation of hypericin photodynamic therapy by pretreatment with 12 various inhibitors of arachidonic acid metabolism in colon adenocarcinoma HT-29 cells

Photochemistry and Photobiology

Volumn 83, Issue 5, 2007, Pages 1174-1185

  Kleban, Ján ^a   Mikeš, Jaromír ^a   Szilárdiová, Beáta ^a   Kovaľ, Ján ^a   Sačková, Veronika ^a   Solár, Peter ^a   Horváth, Viktor ^b   Hofmanová, Jiřina ^b   Kozubík, Alois ^b   Fedoročko, Peter ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DRUG DERIVATIVE; HYPERICIN; PERYLENE;

ADENOCARCINOMA; ARTICLE; CELL STRAIN HT29; COLON TUMOR; DRUG ANTAGONISM; HUMAN; METABOLISM; PATHOLOGY; PHOTOCHEMOTHERAPY;

ADENOCARCINOMA; ARACHIDONIC ACID; COLONIC NEOPLASMS; HT29 CELLS; HUMANS; PERYLENE; PHOTOCHEMOTHERAPY;

EID: 34548708008     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2007.00127.x     Document Type: Article

References (56)

1. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan Q. Peng (1998) Photodynamic therapy. J. Natl Cancer Inst. 90, 889 905.
2. Vantieghem, A., Y. Xu, W. Declercq, P. Vandenabeele, G. Denecker, J. R. Vandenheede, W. Merlevede, P. A. de Witte P. Agostinis (2001) Different pathways mediate cytochrome c release after photodynamic therapy with hypericin. Photochem. Photobiol. 74, 133 142.
3. Agostinis, P., A. Vantieghem, W. Merlevede P. A. de Witte (2002) Hypericin in cancer treatment: More light on the way. Int. J. Biochem. Cell Biol. 34, 221 241.
4. Cavarga, I., P. Brezani, M. Cekanova-Figurova, P. Solar, P. Fedorocko P. Miskovsky (2001) Photodynamic therapy of murine fibrosarcoma with topical and systemic administration of hypericin. Phytomedicine 8, 325 330.
5. Cavarga, I., P. Brezani, P. Fedorocko, P. Miskovsky, N. Bobrov, F. Longauer, S. Rybarova, L. Mirossay J. Stubna (2005) Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing. Phytomedicine 12, 680 683.
6. Solar, P., I. Cavarga, J. Hofmanova, M. Cekanova-Figurova, P. Miskovsky, P. Brezani, G. Hrckova, A. Kozubik P. Fedorocko (2002) Effect of acetazolamide on hypericin photocytotoxicity. Planta Med. 68, 658 660.
7. Agostinis, P., Z. Assefa, A. Vantieghem, J. R. Vandenheede, W. Merlevede P. De Witte (2000) Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin. Adv. Enzyme Regul. 40, 157 182.
8. Matroule, J. Y., C. M. Carthy, D. J. Granville, O. Jolois, D. W. Hunt J. Piette (2001) Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide-a methylester photosensitization. Oncogene 20, 4070 4084.
9. Moor, A. C. (2000) Signaling pathways in cell death and survival after photodynamic therapy. J. Photochem. Photobiol. B 57, 1 13.
10. Kobayashi, W., Q. Liu, T. Matsumiya, H. Nakagawa, H. Yoshida, T. Imaizumi, K. Satoh H. Kimura (2004) Photodynamic therapy upregulates expression of Mac-1 and generation of leukotriene B(4) by human polymorphonuclear leukocytes. Oral. Oncol. 40, 506 510.
11. Panossian, A. G., E. Gabrielian, V. Manvelian, K. Jurcic H. Wagner (1996) Immunosuppressive effects of hypericin on stimulated human leukocytes: Inhibition of the arachidonic acid release, leukotriene B-4 and interleukin-1 alpha production, and activation of nitric oxide formation. Phytomedicine 3, 19 28.
12. Ghosh, J. C. E. Myers (1999) Central role of arachidonate 5-lipoxygenase in the regulation of cell growth and apoptosis in human prostate cancer cells. Adv. Exp. Med. Biol. 469, 577 582.
13. Kozubik, A., J. Hofmanova, L. Dusek E. Musilova (1997) 5-Lipoxygenase inhibitors potentiate effects of TGF-beta 1 on the differentiation of human leukemia HL-60 cells. J. Leukoc. Biol. 62, 240 248.
14. Steele, V. E., C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman G. J. Kelloff (1999) Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev. 8, 467 483.
15. Henderson, B. W. J. M. Donovan (1989) Release of prostaglandin E2 from cells by photodynamic treatment in vitro. Cancer Res. 49, 6896 6900.
16. Penning, L. C., M. J. Keirse, J. Van Steveninck T. M. Dubbelman (1993) Ca(2+)-mediated prostaglandin E2 induction reduces haematoporphyrin-derivative- induced cytotoxicity of T24 human bladder transitional carcinoma cells in vitro. Biochem. J. 292 (Pt 1 237 240.
17. Foultier, M. T., T. Patrice, S. Yactayo, Y. Lajat F. Resche (1992) Photodynamic treatment of normal endothelial cells or glioma cells in vitro. Surg. Neurol. 37, 83 88.
18. Ferrario, A., K. Von Tiehl, S. Wong, M. Luna C. J. Gomer (2002) Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response. Cancer Res. 62, 3956 3961.
19. Hendrickx, N., M. Dewaele, E. Buytaert, G. Marsboom, S. Janssens, M. Van Boven, J. R. Vandenheede, P. de Witte P. Agostinis (2005) Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy. Biochem. Biophys. Res. Commun. 337, 928 935.
20. Hendrickx, N., C. Volanti, U. Moens, O. M. Seternes, P. de Witte, J. R. Vandenheede, J. Piette P. Agostinis (2003) Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J. Biol. Chem. 278, 52231 52239.
21. Sackova, V., P. Fedorocko, B. Szilardiova, J. Mikes J. Kleban (2006) Hypericin-induced photocytotoxicity is connected with G2/M arrest in HT-29 and S phase arrest in U937 cells. Photochem. Photobiol. 82, 1285 1291.
22. Gugliucci, A., L. Ranzato, L. Scorrano, R. Colonna, V. Petronilli, C. Cusan, M. Prato, M. Mancini, F. Pagano P. Bernardi (2002) Mitochondria are direct targets of the lipoxygenase inhibitor MK886. A strategy for cell killing by combined treatment with MK886 and cyclooxygenase inhibitors. J. Biol. Chem. 277, 31789 31795.
23. Bisland, S. K., J. W. Austin, D. P. Hubert L. Lilge (2004) Photodynamic actinometry using microspheres: Concept, development and responsivity. Photochem. Photobiol. 79, 371 378.
24. Agarwal, M. L., H. E. Larkin, S. I. Zaidi, H. Mukhtar N. L. Oleinick (1993) Phospholipase activation triggers apoptosis in photosensitized mouse lymphoma cells. Cancer Res. 53, 5897 5902.
25. Hong, S. H., I. Avis, M. D. Vos, A. Martinez, A. M. Treston J. L. Mulshine (1999) Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res. 59, 2223 2228.
26. Anderson, K. M., T. Seed, M. Vos, J. Mulshine, J. Meng, W. Alrefai, D. Ou J. E. Harris (1998) 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death. Prostate 37, 161 173.
27. Ghosh, J. C. E. Myers (1998) Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl Acad. Sci. USA 95, 13182 13187.
28. Datta, K., S. S. Biswal, J. Xu, K. M. Towndrow, X. Feng J. P. Kehrer (1998) A relationship between 5-lipoxygenase-activating protein and bcl-xL expression in murine pro-B lymphocytic FL5.12 cells. J. Biol. Chem. 273, 28163 28169.
29. Wu, X., S. S. Biswal J. P. Kehrer (2003) Roles of 5-lipoxygenase activating protein in cell proliferation and apoptosis. Cell Biol. Toxicol. 19, 135 143.
30. Ghosh, J. C. E. Myers (1997) Arachidonic acid stimulates prostate cancer cell growth: Critical role of 5-lipoxygenase. Biochem. Biophys. Res. Commun. 235, 418 423.
31. Leung, H. W., W. H. Yang, M. Y. Lai, C. J. Lin H. Z. Lee (2006) Inhibition of 12-lipoxygenase during baicalein-induced human lung nonsmall carcinoma H460 cell apoptosis. Food Chem. Toxicol. 45, 403 411.
32. Wong, B. C., W. P. Wang, C. H. Cho, X. M. Fan, M. C. Lin, H. F. Kung S. K. Lam (2001) 12-Lipoxygenase inhibition induced apoptosis in human gastric cancer cells. Carcinogenesis 22, 1349 1354.
33. Yoshimura, R., K. Inoue, Y. Kawahito, M. Mitsuhashi, K. Tsuchida, M. Matsuyama, H. Sano T. Nakatani (2004) Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor. Int. J. Mol. Med. 13, 41 46.
34. Kudryavtsev, I. A., M. V. Gudkova, O. M. Pavlova, A. E. Oreshkin N. V. Myasishcheva (2005) Lipoxygenase pathway of arachidonic acid metabolism in growth control of tumor cells of different type. Biochemistry (Mosc.) 70, 1396 1403.
35. Hoferova, Z., P. Fedorocko, M. Hofer, J. Hofmanova, A. Kozubik V. Eliasova (2003) Lipoxygenase inhibitors suppress proliferation of G5:113 fibrosarcoma cells in vitro but they have no anticancer activity in vivo. Neoplasma 50, 102 109.
36. Hofmanova, J., A. Kozubik, L. Dusek J. Pachernik (1998) Inhibitors of lipoxygenase metabolism exert synergistic effects with retinoic acid on differentiation of human leukemia HL-60 cells. Eur. J. Pharmacol. 350, 273 284.
37. Hofmanova, J., K. Soucek, J. Pachernik, M. Kovarikova, Z. Hoferova, K. Minksova, J. Netikova A. Kozubik (2002) Lipoxygenase inhibitors induce arrest of tumor cells in S-phase of the cell cycle. Neoplasma 49, 362 367.
38. Kuo, H. C., H. J. Lee, C. C. Hu, H. I. Shun T. H. Tseng (2006) Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells. Toxicol. Appl. Pharmacol. 210, 55 62.
39. Wang, C. J., Y. J. Hsieh, C. Y. Chu, Y. L. Lin T. H. Tseng (2002) Inhibition of cell cycle progression in human leukemia HL-60 cells by esculetin. Cancer Lett. 183, 163 168.
40. Hoferová, Z., K. Soucek, J. Hofmanova, M. Hofer, K. Chramostova, P. Fedorocko A. Kozubik (2004) In vitro proliferation of fibrosarcoma cells depends on intact functions of lipoxygenases and cytochrome P-450-monooxygenase. Cancer Invest. 22, 234 247.
41. Shiff, S. J., M. I. Koutsos, L. Qiao B. Rigas (1996) Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis. Exp. Cell Res. 222, 179 188.
42. Grosch, S., I. Tegeder, K. Schilling, T. J. Maier, E. Niederberger G. Geisslinger (2003) Activation of c-Jun-N-terminal-kinase is crucial for the induction of a cell cycle arrest in human colon carcinoma cells caused by flurbiprofen enantiomers. FASEB J. 17, 1316 1318.
43. Grosch, S., K. Schilling, A. Janssen, T. J. Maier, E. Niederberger G. Geisslinger (2005) Induction of apoptosis by R-flurbiprofen in human colon carcinoma cells: Involvement of p53. Biochem. Pharmacol. 69, 831 839.
44. Janssen, A., T. J. Maier, S. Schiffmann, O. Coste, M. Seegel, G. Geisslinger S. Grosch (2006) Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment. Eur. J. Pharmacol. 540, 24 33.
45. Wang, H. M. G. Y. Zhang (2004) [Effect of indomethacin on human colorectal cancer cells HCT116 and SW480]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 29, 28 31.
46. Kato, M., S. Nishida, H. Kitasato, N. Sakata S. Kawai (2001) Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: Investigation using human peripheral monocytes. J. Pharm. Pharmacol. 53, 1679 1685.
47. Kundu, N., M. J. Smyth, L. Samsel A. M. Fulton (2002) Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle. Breast Cancer Res. Treat. 76, 57 64.
48. Lee, E., M. K. Choi, H. J. Youk, C. H. Kim, I. O. Han, B. C. Yoo, M. K. Lee S. J. Lim (2006) 5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3- trifluoromethylpyrazole acts in a reactive oxygen species-dependent manner to suppress human lung cancer growth. J. Cancer Res. Clin. Oncol. 132, 223 233.
49. Grosch, S., T. J. Maier, S. Schiffmann G. Geisslinger (2006) Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J. Natl Cancer Inst. 98, 736 747.
50. Henry, D., L. L. Lim, L. A. Garcia Rodriguez, S. Perez Gutthann, J. L. Carson, M. Griffin, R. Savage, R. Logan, Y. Moride, C. Hawkey, S. Hill J. T. Fries (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis. BMJ 312, 1563 1566.
51. Warner, T. D., F. Giuliano, I. Vojnovic, A. Bukasa, J. A. Mitchell J. R. Vane (1999) Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc. Natl Acad. Sci. USA 96, 7563 7568.
52. Baek, S. J., J. S. Kim, S. M. Moore, S. H. Lee, J. Martinez T. E. Eling (2005) Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein. Mol. Pharmacol. 67, 356 364.
53. Baek, S. J., K. S. Kim, J. B. Nixon, L. C. Wilson T. E. Eling (2001) Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol. Pharmacol. 59, 901 908.
54. Baldwin, G. S., V. J. Murphy, Z. Yang T. Hashimoto (1998) Binding of nonsteroidal antiinflammatory drugs to the alpha-subunit of the trifunctional protein of long chain fatty acid oxidation. J. Pharmacol. Exp. Ther. 286, 1110 1114.
55. Yamazaki, T., M. Muramoto, T. Oe, N. Morikawa, O. Okitsu, T. Nagashima, S. Nishimura, Y. Katayama Y. Kita (2006) Diclofenac, a non-steroidal anti-inflammatory drug, suppresses apoptosis induced by endoplasmic reticulum stresses by inhibiting caspase signaling. Neuropharmacology 50, 558 567.
56. Kleban, J., B. Szilardiova, J. Mikes, V. Horvath, V. Sackova, P. Brezani, J. Hofmanova, A. Kozubik P. Fedorocko (2006) Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin. J. Photochem. Photobiol. B 84, 79 88.